<div id="readability-page-1"><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks </li></ul>Non-Invasive Monitoring Systems ( (NIMU) ) has shared an announcement. On May 7, 2026, Non-Invasive Monitoring Systems, Inc. entered into a $200,000 promissory note with Frost Gamma Investments Trust, a vehicle controlled by board member and major shareholder Dr. Phillip Frost, carrying an 11% annual interest rate and maturing on June 30, 2026, with no penalty for early prepayment. On the same date, the company also executed a $100,000 promissory note with its Chairman and Interim CEO, Jane Hsiao, under identical terms, underscoring the firm’s reliance on insider financing for short-term liquidity needs and highlighting the close alignment between management and the company’s capital structure. These insider-funded notes suggest that Non-Invasive Monitoring Systems is tapping its major shareholders for near-term funding rather than seeking external lenders, which may provide flexibility but also concentrate financial influence among key insiders who already hold significant equity stakes in the company. More about Non-Invasive Monitoring Systems Non-Invasive Monitoring Systems, Inc. operates in the medical technology sector, focusing on non-invasive monitoring solutions, and its common stock is significantly held by key insiders, including board member Dr. Phillip Frost and Chairman and Interim Chief Executive Officer Jane Hsiao, each owning more than 10% of the company’s shares. Average Trading Volume: 148,083 Technical Sentiment Signal: Buy Current Market Cap: $10.84M See more insights into NIMU stock on TipRanks’ Stock Analysis page.</div>

MMSI

INSP

Non-Invasive Monitoring Systems, Inc. has announced a $200,000 promissory note with Frost Gamma Investments Trust and a $100,000 note with its Chairman, Jane Hsiao, both maturing on June 30, 2026, at an 11% interest rate. This insider financing highlights the company's reliance on major shareholders for short-term liquidity, indicating a close alignment between management and capital structure. The company operates in the medical technology sector, with significant insider ownership.

Non-Invasive Monitoring Secures Insider-Funded Short-Term Financing